105 related articles for article (PubMed ID: 1712558)
21. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
22. Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40.
Gordon J; Millsum MJ; Flores-Romo L; Gillis S
Immunology; 1989 Dec; 68(4):526-31. PubMed ID: 2481643
[TBL] [Abstract][Full Text] [Related]
23. Initiation in DNA synthesis by colony-stimulating factors in subsets of human CD34+ marrow cells.
Strauss LC; Welsh SB; Civin CI
Exp Hematol; 1991 Sep; 19(8):734-41. PubMed ID: 1714400
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR
Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
[TBL] [Abstract][Full Text] [Related]
25. Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells.
Saeland S; Duvert V; Caux C; Pandrau D; Favre C; Vallé A; Durand I; Charbord P; de Vries J; Banchereau J
Exp Hematol; 1992 Jan; 20(1):24-33. PubMed ID: 1374342
[TBL] [Abstract][Full Text] [Related]
26. CD23 and B cell activation.
Gordon J
Clin Exp Allergy; 1992 Feb; 22(2):199-204. PubMed ID: 1533341
[No Abstract] [Full Text] [Related]
27. Human B cell precursors proliferate and express CD23 after CD40 ligation.
Saeland S; Duvert V; Moreau I; Banchereau J
J Exp Med; 1993 Jul; 178(1):113-20. PubMed ID: 7686210
[TBL] [Abstract][Full Text] [Related]
28. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
Gore SD; Amin S; Weng LJ; Civin CI
Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
[TBL] [Abstract][Full Text] [Related]
29. Responsiveness of AML cells to recombinant hematopoietic growth factors: relationship with morphological and immunological characteristics of blast cells.
Almeida J; Consuelo Del Cañizo M; Galende J; San Miguel JF
Leuk Res; 1996 Jun; 20(6):533-4. PubMed ID: 8709627
[No Abstract] [Full Text] [Related]
30. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
Gordon J; Katira A; Strain AJ; Gillis S
Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
[TBL] [Abstract][Full Text] [Related]
32. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
Gazzola MV; Collins NH; Tafuri A; Keever CA
Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
[TBL] [Abstract][Full Text] [Related]
33. Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon-gamma.
Chrétien I; Pène J; Brière F; De Waal Malefijt R; Rousset F; De Vries JE
Eur J Immunol; 1990 Feb; 20(2):243-51. PubMed ID: 2138081
[TBL] [Abstract][Full Text] [Related]
34. Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody.
Soligo D; Delia D; Oriani A; Cattoretti G; Orazi A; Bertolli V; Quirici N; Deliliers GL
Leukemia; 1991 Dec; 5(12):1026-30. PubMed ID: 1723130
[TBL] [Abstract][Full Text] [Related]
35. Similarity of p53 expression by CD34+ cells in chronic myeloid leukemia and normal progenitors detected by flow cytometry.
Lanza F; Bi S; Goldman JM
Blood; 1992 Oct; 80(7):1857-8. PubMed ID: 1382707
[No Abstract] [Full Text] [Related]
36. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
[TBL] [Abstract][Full Text] [Related]
37. Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR- bone marrow cells.
Srour EF; Brandt JE; Leemhuis T; Ballas CB; Hoffman R
J Immunol; 1992 Feb; 148(3):815-20. PubMed ID: 1370518
[TBL] [Abstract][Full Text] [Related]
38. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
Akabutu JJ; Chan JR
Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
[No Abstract] [Full Text] [Related]
39. Affinity-purified soluble Fc epsilon RII/CD23 derived from a culture supernatant of an EBV-immortalized B-cell line induced a monophasic fever in rabbits.
Ghaderi AA; Stanworth DR
Immunology; 1991 Aug; 73(4):510-1. PubMed ID: 1655640
[TBL] [Abstract][Full Text] [Related]
40. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE.
Sarfati M; Delespesse G
J Immunol; 1988 Oct; 141(7):2195-9. PubMed ID: 2971721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
